Lemaitre Vascular (LMAT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 39,561 | 39,503 | 38,368 | 40,670 | 35,883 |
| Cost of Goods | 13,599 | 13,547 | 13,502 | 13,909 | 12,084 |
| Gross Profit | 25,962 | 25,956 | 24,866 | 26,761 | 23,799 |
| Operating Expenses | 18,633 | 18,202 | 16,295 | 16,564 | 15,938 |
| Operating Income | 7,928 | 8,301 | 9,073 | 11,106 | 7,945 |
| Interest Expense | 0 | 526 | 621 | 495 | 577 |
| Other Income | 68 | 130 | -18 | -156 | 125 |
| Pre-tax Income | 7,996 | 7,905 | 8,434 | 10,455 | 7,493 |
| Income Tax | 1,958 | 1,730 | 1,930 | 2,156 | 1,564 |
| Net Income Continuous | 6,038 | 6,175 | 6,504 | 8,299 | 5,929 |
| Net Income | $6,038 | $6,175 | $6,504 | $8,299 | $5,929 |
| EPS Basic Total Ops | 0.28 | 0.28 | 0.30 | 0.40 | 0.29 |
| EPS Basic Continuous Ops | 0.28 | 0.28 | 0.30 | 0.40 | 0.29 |
| EPS Diluted Total Ops | 0.27 | 0.27 | 0.30 | 0.40 | 0.28 |
| EPS Diluted Continuous Ops | 0.27 | 0.28 | 0.30 | 0.40 | 0.28 |
| EBITDA(a) | $10,301 | $11,185 | $11,998 | $13,743 | $10,569 |